|
|
||||||||||||||
|
|
|||||||||||||||
|
Published Online First: 15 May 2007. doi:10.1136/bjo.2006.113803 British Journal of Ophthalmology 2007;91:1524-1527 Copyright © 2007 by the BMJ Publishing Group Ltd.
Non-arteritic anterior ischaemic optic neuropathy and presumed sleep apnoea syndrome screened by the Sleep Apnea scale of the Sleep Disorders Questionnaire (SA-SDQ)Jian Li1, Gerald McGwin Jr1,2, Michael S Vaphiades2, Cynthia Owsley2
1 Department of Epidemiology and International Health, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama
Correspondence to: Background: Two recent studies reported over 70% of the patients with non-arteritic anterior ischaemic optic neuropathy (NAION) had sleep apnoea syndrome (SAS) diagnosed by overnight polysomnography. The current study used the Sleep Apnea scale of the Sleep Disorders Questionnaire (SA-SDQ) to evaluate this association. Methods: A matched case-control study was conducted among 73 cases of NAION matched on age and gender to 73 controls without a history of NAION. Information regarding demographics, medical conditions, health behaviours and SAS was obtained via a telephone questionnaire that included the SA-SDQ. Conditional logistic regression was used to calculate odds ratios (OR) and the 95% confidence intervals (CI) for the association between NAION and the SA-SDQ. Results: Cases were significantly more likely to report symptoms and characteristics consistent with SAS than controls (OR 2.62; 95% CI 1.03 to 6.60) when adjusted for medical and health behaviour characteristics. Conclusions: The results of this study suggest that patients with SAS are at increased risk of NAION. Additional research in a larger population is needed to confirm the observed results and validate the use of the SA-SDQ in patients with NAION.
Abbreviations: COPD, chronic obstructive pulmonary disease, NAION, non-arteritic anterior ischaemic optic neuropathy; SAS, sleep apnoea syndrome; SA-SDQ, Sleep Apnea scale of the Sleep Disorders Questionnaire Competing interests: None declared. Funding: This research was supported by National Institute on Aging Grant R01-AG04212, National Eye Institute Grant R21-EY14071, Research to Prevent Blindness, Inc., and the EyeSight Foundation of Alabama. CO is a Research to Prevent Blindness Senior Scientific Investigator.
Related Article
Read all eLetters |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |